PRL-8-53
11 Inquiries
51352-87-5
Pharmaceutical Grade
98%
Bag for orders <5kg | Cardboard drum for bigger orders
2024-06-01
Nootropics,Sarms,Peptides,API,Intermediates
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
PRL-8-53
Other Name:PRL-8053;PRL-8-53;Methyl 3-(2-(benzyl(Methyl)aMino)ethyl)benzoate hydrochloride;PRL-8-53 HCL;3-(2-Benzyl(methyl)aminoethyl)benzoic acid methyl ester hydrochloride;m-[2-(Benzylmethylamino)ethyl]benzoic acid methyl ester hydrochloride;Benzoic acid, 3-(2-(Methyl(phenylMethyl)aMino)ethyl)-, Methyl ester, hydrochloride;Methyl 3-(2-(benzyl(methyl)
CAS No.:51352-87-5
Molecular Formula:C18H22ClNO2
InChIKeys:HLBBSWSJLPLPRU-UHFFFAOYSA-N
Molecular Weight:319.82578
EC Number:206-141-6
Categories:
Characteristics-
Toxicity:
PRL-8-53 is relatively non-toxic, with an oral LD50 in mice of 860 mg/kg, giving the drug a high therapeutic index. Doses above 8 mg/kg have brief hypotensive effects in canines. High doses depress motor activity in the rat and mouse, with the ED50 for a 50% reduction in motor activity of mice at 160 mg/kg. PRL-8-53 displays spasmolytic effects.
Critical Temperature & Pressure:under inert gas (nitrogen or Argon) at 2-8°C
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Nootropics,Sarms,Peptides,API,Intermediates
-
Location:
Kemp House, 160 City Road London, EC1V 2NX
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Average lead Time:
2
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
Less than 5
-
Year of Establishment:
2021
-
-
Inquiry History11 Inquiries
Country Product Purchase Quantity Date Posted 
Russia
PRL-8-53
10.00 G Aug 14, 2024 
United States
PRL-8-53
1 G Feb 2, 2025
Russia
Sofosbuvir
68.00 G Aug 14, 2024
Russia
7,8-Dihydroxyflavone
75.00 G Aug 14, 2024
Russia
Citicoline sodium
750.00 G Aug 14, 2024
Russia
Enclomiphene
100.00 G Aug 14, 2024
Russia
NNMTi
15.00 G Aug 14, 2024
Russia
Velpatasvir
17.00 G Aug 14, 2024
Russia
Unifiram
30.00 G Aug 14, 2024
Russia
Coluracetam
100.00 G Aug 14, 2024
Russia
DIHEXA
50.00 G Aug 14, 2024 Post an enquiry for this product